National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information: (updated June 19, 2026)
| Drug Products on Critical Shortage | |
| Drug Name | Details |
| epoprostenol Glycine (Flolan®) | Supply is critical. Est release: Jul 2026. |
| morphine 100mg ER tablet | Supply is critical Est. release: Jun 2026 |
| pantoprazole oral suspension | Supply is depleted. Est. release: Jul 2026 |
| penicillin G benzathine injectable | Supply is critical. Est release: Nov 2026 (1.2MU and 2.4MU), Nov 2027 (0.6MU) |
| Drug Products on Shortage - Limited Availability | |
| Drug Name | Details |
| eravacycline 50mg vial | Supply is limited. Est. release: Jul 2026 |
| hydromorphone PF injectable | Supply is limited. Est. release: Jul 2026 |
| iodinated contrast (Omnipaque®) | Supply of most strengths/sizes are limited. Est. release unpredictable |
| trastuzumab-dkst (Ogivri®) 150mg | Supply is limited. Est. release: none |
| Relevant Products on National Shortage – No Practice Changes Needed | |
| Drug Name | Details |
| carboplatin injectable | Supply is adequate to meet needs. |
| fluorescein ophthalmic strips | Supply is adequate to meet needs. |
| ifosfamide injectable | Supply is adequate to meet needs. |
| Discontinued (no longer being manufactured) | |
| Drug Name | Notes/Information |
| chlorothiazide oral | Diuril oral suspension, Bausch Health, 250 mg / 5 mL 237 mL bottle, NDC 65649-0311-12 - discontinued. There are no products available. |
| dextrose-lidocaine 7.5%-5% 2mL | Pfizer discontinued 5% lidocaine and 7.5% dextrose 2 mL ampules. Pfizer is the sole supplier of this combination. |
| lindane products | All presentations have been discontinued FDA Orange Book |
| testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |